Antabuse (Teva Women’s Health, Inc.)
Welcome to the PulseAid listing for the Antabuse drug offered from Teva Women’s Health, Inc.. This Acetyl Aldehyde Dehydrogenase Inhibitors [MoA],Aldehyde Dehydrogenase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Women’s Health, Inc. |
| NON-PROPRIETARY NAME: | Disulfiram |
| SUBSTANCE NAME: | DISULFIRAM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acetyl Aldehyde Dehydrogenase Inhibitors [MoA],Aldehyde Dehydrogenase Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2000-12-01 |
| END MARKETING DATE: | 0000-00-00 |
Antabuse HUMAN PRESCRIPTION DRUG Details:
| Item Description | Antabuse from Teva Women’s Health, Inc. |
| LABELER NAME: | Teva Women’s Health, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2000-12-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51285-523_d635d91c-e9c2-4525-b3be-8089c858c6d2 |
| PRODUCT NDC: | 51285-523 |
| APPLICATION NUMBER: | ANDA088482 |
Other DISULFIRAM Pharmaceutical Manufacturers / Labelers:
